TrialScientific reports2023
Efficacy and safety of eltrombopag in Chinese patients with refractory or relapsed severe aplastic anemia.
Hong Chang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it